These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9426438

  • 21. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S, Suárez HG.
    Oncogene; 1995 Nov 02; 11(9):1907-11. PubMed ID: 7478621
    [Abstract] [Full Text] [Related]

  • 22. Renal expression of two 'thyroid-specific' genes: thyrotropin receptor and thyroglobulin.
    Sellitti DF, Akamizu T, Doi SQ, Kim GH, Kariyil JT, Kopchik JJ, Koshiyama H.
    Exp Nephrol; 2000 Nov 02; 8(4-5):235-43. PubMed ID: 10940722
    [Abstract] [Full Text] [Related]

  • 23. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD.
    Mol Endocrinol; 1993 Aug 02; 7(8):1009-20. PubMed ID: 7901757
    [Abstract] [Full Text] [Related]

  • 24. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E, Musholt PB, Potter E, Petrich T, Wehmeier M, von Wasielewski R, Lichtinghagen R, Musholt TJ.
    Br J Cancer; 2005 Sep 05; 93(5):565-70. PubMed ID: 16091757
    [Abstract] [Full Text] [Related]

  • 25. Heterologous desensitization in neoplastic thyroid cells: influence of the phospholipase C signal transduction system on the thyrotropin-adenylate cyclase signal transduction system.
    Tezelman S, Hoelting T, Jossart GH, Wong MG, Siperstein AE, Duh QY, Clark OH.
    World J Surg; 1998 Jun 05; 22(6):544-51. PubMed ID: 9597926
    [Abstract] [Full Text] [Related]

  • 26. Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes.
    van Staveren WC, Beeckman S, Tomás G, Dom G, Hébrant A, Delys L, Vliem MJ, Trésallet C, Andry G, Franc B, Libert F, Dumont JE, Maenhaut C.
    Exp Cell Res; 2012 Mar 10; 318(5):444-52. PubMed ID: 22240166
    [Abstract] [Full Text] [Related]

  • 27. Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5.
    van der Kallen CJ, Coes JH, van Grafhorst JP, Schuuring EM, Ossendorp FA, Thijssen JH, Blankenstein MA, de Bruin TW.
    Br J Cancer; 1996 Aug 10; 74(4):606-12. PubMed ID: 8761378
    [Abstract] [Full Text] [Related]

  • 28. Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells.
    Inoue M, Tawata M, Yokomori N, Endo T, Onaya T.
    Thyroid; 1998 Nov 10; 8(11):1059-64. PubMed ID: 9848724
    [Abstract] [Full Text] [Related]

  • 29. The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor.
    Chazenbalk GD, Nagayama Y, Kaufman KD, Rapoport B.
    Endocrinology; 1990 Sep 10; 127(3):1240-4. PubMed ID: 2167212
    [Abstract] [Full Text] [Related]

  • 30. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
    Lu C, Zhao L, Ying H, Willingham MC, Cheng SY.
    Endocrinology; 2010 Apr 10; 151(4):1929-39. PubMed ID: 20133453
    [Abstract] [Full Text] [Related]

  • 31. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
    Broecker M, Mayr GW, Derwahl M.
    Endocrinology; 1997 Sep 10; 138(9):3787-96. PubMed ID: 9275066
    [Abstract] [Full Text] [Related]

  • 32. Desensitization of cyclic adenosine 3,5'-monophosphate response to thyrotropin in normal and primary or metastatic papillary thyroid cancer cells in vitro.
    Tezelman S, Siperstein AE, Duh QY, Wong MG, Clark OH.
    Surgery; 1996 Dec 10; 120(6):926-33. PubMed ID: 8957475
    [Abstract] [Full Text] [Related]

  • 33. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
    Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE, Vassart G.
    J Clin Endocrinol Metab; 1997 Aug 10; 82(8):2695-701. PubMed ID: 9253356
    [Abstract] [Full Text] [Related]

  • 34. Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'-monophosphate, but by Ca2+ signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative.
    Kimura T, Okajima F, Sho K, Kobayashi I, Kondo Y.
    Endocrinology; 1995 Jan 10; 136(1):116-23. PubMed ID: 7828520
    [Abstract] [Full Text] [Related]

  • 35. The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas.
    Brunetti A, Chiefari E, Filetti S, Russo D.
    Endocrinology; 2000 Feb 10; 141(2):722-30. PubMed ID: 10650954
    [Abstract] [Full Text] [Related]

  • 36. 12-O-tetradecanoyl-phorbol-13-acetate (TPA) counteracts the cAMP up-regulation of the expression of the stimulatory guanine nucleotide binding protein (Gs alpha) and Gs alpha messenger RNA in cultured pig thyroid cells.
    Dib K, Delemer B, el Jamali A, Haye B, Jacquemin C, Corrèze C.
    Mol Cell Endocrinol; 1994 Mar 10; 99(2):229-35. PubMed ID: 8206331
    [Abstract] [Full Text] [Related]

  • 37. Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells.
    Saji M, Akamizu T, Sanchez M, Obici S, Avvedimento E, Gottesman ME, Kohn LD.
    Endocrinology; 1992 Jan 10; 130(1):520-33. PubMed ID: 1309347
    [Abstract] [Full Text] [Related]

  • 38. Growth suppression of thyroid cancer cells by adenylcyclase activator.
    Yano Y, Kamma H, Matsumoto H, Fujiwara M, Bando H, Hara H, Yashiro T, Ueno E, Ito K, Uchida K.
    Oncol Rep; 2007 Aug 10; 18(2):441-5. PubMed ID: 17611668
    [Abstract] [Full Text] [Related]

  • 39. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
    Kamiya Y, Murakami M, Yanagita Y, Koitabashi H, Nagamachi Y, Hosoi Y, Ogiwara T, Mizuma H, Iriuchijima T, Mori M.
    Mol Cell Endocrinol; 1998 Mar 16; 138(1-2):137-42. PubMed ID: 9685222
    [Abstract] [Full Text] [Related]

  • 40. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I, Lima L, Seoane R, Lado-Abeal J.
    Thyroid; 2009 Jun 16; 19(6):645-9. PubMed ID: 19499991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.